Functional profiling of IL-6-driven JAK-STAT signalling as a basis for personalised therapy in rheumatoid arthritis

tofacitinib - Generic mfg.

Jyseleca (filgotinib) - Gilead

Rinvoq (upadacitinib) - AbbVie

Olumiant (baricitinib) - Eli Lilly

https://distribution-congress.eular.org/from.storage?image=15rRXWmdOAJ77zPlkD-rQq_GVCZQF3ZHXnWcYLLyZCm8XFVFix_X1c1Tziep74nB0

David Nagy1; Beáta Horváth1; Lilla Gunkl-Tóth1, 2, 3; Dora Nemeth1, 4; Panna Királyhidi1, 4; Gabor Turu5, 6; Tamás Németh1, 5, 7, 8; György Nagy1, 4, 8

May 23, 2026